Large BiotechUSBIIBAggressive Acquisition Appetite
Biogen Deal History & Licensing Activity
Biogen is a large biotech headquartered in US. Over the past three years, Biogen has been involved in 39 licensing and acquisition transactions, with a primary focus on Antibodies (14 deals). The company currently has 50 active clinical trials, primarily in Oncology.
Deals (12mo)
14
Active Trials
50
Top Modality
Antibodies
Focus Area
Oncology
Biogen Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Biogen in the past 12 months.
| Asset |
|---|